Cuba's Soberana Plus vaccine candidate against Covid-19 is currently showing encouraging results by considerably raising antibodies in Covid-19 convalescents with only one dose.
The province of Holguín prepares the conditions to begin in the next few days the intervention with the vaccine candidate Abdala in risk groups, specifically with health workers, students of Medical Sciences and other vulnerable people in the territory.
A project to determine the genetic predisposition of patients with Spinocerebellar Ataxia type II (SCA2) to suffer from COVID-19 is being developed by specialists from Holguín, the Cuban province with the highest prevalence of this disease.
As part of the measures to tackle COVID-19 in the province of Holguin, the health system is expanding community population studies as part of the strategies to prevent infection with such a highly contagious virus.
Cuban President Miguel Díaz-Canel, along with experts and scientists, reviewed the new research works to curb Covid-19 incidence and consequences in lungs.